Dr. rer. nat. Jörg Haupental is a senior scientist (biologist) in Prof. Anna Hirsch’s research department at HIPS. After researching novel anti-cancer drugs for several years, he started focusing on the development of anti-infective agents in 2009. In the context of the biological evaluation of novel anti-infectives (under in vivo, ex vivo and in vitro conditions) he supervises master and Ph.D. students and coordinates several technicians. Together with Prof. Dr. Anna K.H. Hirsch, he leads a CARB-X funded project aiming at the development of novel Pseudomonas aeruginosa LasB inhibitors for the treatment of acute lung infections. Jörg Haupenthal is biological safety officer at DDOP and radiation protection commissioner at HIPS. He is an author and co-author of more than 50 peer-reviewed scientific publications with over 1,000 citations.